Clinical trial
An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release…
NCT00304681 · Janssen-Ortho Inc., Canada, Industry · Completed
Key facts
| NCT number | NCT00304681 |
|---|---|
| Title | An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children |
| Official title | The Effectiveness of CONCERTA® vs. Usual Clinical Care With Immediate Release Methylphenidate (IR MPH) in Children (6-12 Years) With Attention Deficit Hyperactivity Disorder (ADHD): A Randomized, Open-Label Trial |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | OROS*-Methylphenidate |
| Enrollment | 147 |
| Completion | Feb 1, 2004 |
| First posted | Mar 20, 2006 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: